What are the current challenges that the industry is facing with the implementation of decentralized clinical trials -DCTs- during the COVID-19 pandemic?
How do we design study protocols to accommodate collecting data in the real-world setting of a person’s home or community facility?
Patient recruitment, engagement and retention are increasingly detrimental challenges to successfully conducting a clinical trial.
Data integrity and continuity of collection with Decentralized Clinical Trials (DCTs) is critical and when there are no standards you have to re-invent the wheel every time.
The clinical trial industry is in the midst of major changes. Studies will operate on a spectrum from being localized to one site to being conducted completely electronically.